2013 American Transplant Congress
Rejection Phenotypes, Rejection Timing and Kidney Transplant Outcome
University Hospitals Leuven, Leuven, Belgium
BACKGROUNDThe relative impact of different types of T-cell mediated rejection (borderline changes [BAR], grade 1 or grade 2-3 T-cell mediated rejection [TCMR]) and of antibody-mediated…2013 American Transplant Congress
Comparison of Efficacy and Mechanism of Intact and Fc-Modified Anti-CD154 Antibodies in Tolerance Induction
Emory University, Atlanta, GA; Bristol-Myers Squibb, Princeton, NJ
Blockade of CD40-CD154 interactions during T cell priming has been shown to be a highly effective means of inducing long-term survival of allografts and transplantation…2013 American Transplant Congress
CD68 Positive Glomerulitis Predicts the Development of Transplant Glomerulopathy in Patients with Cellular Rejection
Transplant glomerulopathy [TG] has a very poor prognosis and is almost always associated with eventual graft failure. The risk of TG is increased in patients…2013 American Transplant Congress
C1q-Fixing Human Leukocyte Antigen Antibodies Identified by a C1q Assay Are Associated with Acute and Chronic Rejection in HLA-IgG Positive Kidney Transplant Recipients
Background: Although donor-specific HLA antibodies (DSA) are associated with antibody-mediated rejection (AMR) and poor clinical outcome in kidney transplantation, not all DSAs are harmful to…2013 American Transplant Congress
Living Donor Conversion Rate as a Quality Measure for Kidney Transplant Programs
U of Cincinnati, Cincinnati; Cleveland Clinic, Cleveland; U of British Columbia, Canada
Kidney transplant (KTxp) program quality is assessed by risk adjusted wait list (WL) mortality, time to deceased donor (DD) Txp, and patient (pt) and graft…2013 American Transplant Congress
Should All Type 1 Diabetic Patients (T1DM) Undergo Cardiac Angiography for Transplant Evaluation?
Transplant Surgery, UW Madison, Madison, WI
Objectives: Cardiovascular disease is the leading cause of death after transplantation. Optimal work-up remains controversial. Since 2005, we have performed cardiac catheterization for all T1DM…2013 American Transplant Congress
Early Indicators of Kidney Graft Injury Mediated by Class II Donor Specific Antibodies (DSAII)
Introduction. Pre-transplant DSAII is associated with chronic antibody mediated rejection/transplant glomerulopathy (TG) and high risk of graft loss (GL). However, not all DSAII result in…2013 American Transplant Congress
Expanding the Limits of the Expanded Criteria Donor
Nephrology Division, Hospital do Rim e Hipertensão, Sao Paulo, Brazil
Background: Use of grafts from expanded criteria donors (ECD) has increased significantly in recent years. Acceptable reported outcomes may increase the limits of acceptance and…2013 American Transplant Congress
Risk Factors in Venous Thrombosis of Renal Grafts from Deceased Non Heart-Beating Donors
Nephrology, Hospital 12 Octubre, Madrid, Spain
Background: The deceased donor kidney transplant to non heart-beating may have a higher rate of venous thrombosis (VT).The aim of this study is to analyze…2013 American Transplant Congress
Encapsulated Human Mesenchymal Stem Cells Reduce Alpha-Smooth Muscle Actin and Increase Matrix Metalloproteinase-9 Expression during Liver Fibrosis
INTRODUCTION: Mesenchymal stem cells (MSCs) transplantation has been suggested to be effective for the treatment of liver fibrosis, but the mechanisms of action are not…
- « Previous Page
- 1
- …
- 71
- 72
- 73
- 74
- 75
- …
- 178
- Next Page »